Design, Synthesis and Bioactivity Evaluation of Novel 2-(pyrazol-4-yl)-1,3,4-oxadiazoles Containing an Imidazole Fragment as Antibacterial Agents
Molecules · 2023
DOI: 10.3390/molecules28062442 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Hongwu Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Green Pesticide, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Center for R&D …. Hauptthemen laut MEDLINE: Xanthomonas, Oryza. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, the Guizhou Provincial S&T Project (2018[4007]), the Guizhou Province [Qianjiaohe KY number (2020)004].
Abstract (Originalsprache)
Imidazole alkaloids, a common class of five-membered aromatic heterocyclic compounds, exist widely in plants, animals and marine organisms. Because of imidazole’s extensive and excellent biological and pharmacological activities, it has always been a topic of major interest for researchers and has been widely used as an active moiety in search of bioactive molecules. To find more efficient antibacterial compounds, a series of novel imidazole-fragment-decorated 2-(pyrazol-4-yl)-1,3,4-oxadiazoles were designed and synthesized based on our previous works via the active substructure splicing principle, and their bioactivities were systematically evaluated both in vitro and in vivo. The bioassays showed that some of the target compounds displayed excellent in vitro antibacterial activity toward three virulent phytopathogenic bacteria, including Xanthomonas oryzae pv. oryzae (Xoo), Xanthomonas axonopodis pv. citri (Xac) and Pseudomonas syringae pv. actinidiae (Psa), affording the lowest EC50 values of 7.40 (7c), 5.44 (9a) and 12.85 (9a) μg/mL, respectively. Meanwhile, compound 7c possessed good in vivo protective and curative activities to manage rice bacterial leaf blight at 200 μg/mL, with control efficacies of 47.34% and 41.18%, respectively. Furthermore, compound 9a showed commendable in vivo protective and curative activities to manage kiwifruit bacterial canker at 200 μg/mL, with control efficacies of 46.05% and 32.89%, respectively, which were much better than those of the commercial bactericide TC (31.58% and 17.11%, respectively). In addition, the antibacterial mechanism suggested that these new types of title compounds could negatively impact the cell membranes of phytopathogenic bacteria cells and cause the leakage of the intracellular component, thereby leading to the killing of bacteria. All these findings confirm that novel 2-(pyrazol-4-yl)-1,3,4-oxadiazoles containing an imidazole fragment are promising lead compounds for discovering new bactericidal agents.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Green Pesticide, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Center for R&D of Fine Chemicals of Guizhou University, Guiyang 550025, China.
ORCID-Profile: Peiyi Wang, Xiang Zhou
Förderung
- National Natural Science Foundation of China
- the Guizhou Provincial S&T Project (2018[4007])
- the Guizhou Province [Qianjiaohe KY number (2020)004]
- Program of Introducing Talents of Discipline to Universities of China
- GZU (Guizhou University) Found for Newly Enrolled Talent
- Guizhou Provincial S&T Project
- Guizhou Province
Zitieren
APA
Liu, H., Yang, S., Li, T., Ma, S., Wang, P., Wang, G., Su, S., Ding, Y., Yang, L., Zhou, X., & Yang, S. (2023). Design, Synthesis and Bioactivity Evaluation of Novel 2-(pyrazol-4-yl)-1,3,4-oxadiazoles Containing an Imidazole Fragment as Antibacterial Agents. Molecules. https://doi.org/10.3390/molecules28062442
Vancouver
Liu H, Yang S, Li T, Ma S, Wang P, Wang G, et al. Design, Synthesis and Bioactivity Evaluation of Novel 2-(pyrazol-4-yl)-1,3,4-oxadiazoles Containing an Imidazole Fragment as Antibacterial Agents. Molecules. 2023. doi:10.3390/molecules28062442
BibTeX
@article{Liu2023,
author = {Liu, Hongwu and Yang, Shan and Li, Ting and Ma, Siyue and Wang, Peiyi and Wang, Guoqing and Su, Shanshan and Ding, Yue and Yang, Linli and Zhou, Xiang and Yang, Song},
title = {Design, Synthesis and Bioactivity Evaluation of Novel 2-(pyrazol-4-yl)-1,3,4-oxadiazoles Containing an Imidazole Fragment as Antibacterial Agents},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28062442}
}
EUVIMED